KRAS-mutant cancers: Potential target could overcome treatment resistance
Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is responsible for activation of RAS signaling pathways involved in aggressive tumor growth and resistance ...
Dec 4, 2025
0
15









